Oncology
1 drug is in development for Gall Bladder Cancer.
- Companies
- 1
- Clinical trials
- 6
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Gall Bladder Cancer pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 1/Phase 2(1)
| Drug | Company |
|---|---|
| certepetide | LISATA THERAPEUTICS, INC. (LSTA) |
About this indication
Gall Bladder Cancer context
Oncology·MeSH: Gallbladder Neoplasms (D005706)
Prevalence
61.0 / 100K
Incidence
18.0 / 100K/yr
Frequently asked questions
How many drugs are in development for Gall Bladder Cancer?
BioSniper tracks 1 drug in development for Gall Bladder Cancer across 1 company.
How many clinical trials target Gall Bladder Cancer?
There are 6 clinical trials targeting Gall Bladder Cancer tracked by BioSniper.
What is the prevalence of Gall Bladder Cancer?
The estimated prevalence of Gall Bladder Cancer is approximately 61.0 per 100,000 population.